## Drug of Choice for Depression in Pregnancy **Key Point:** Sertraline is the preferred SSRI for depression management in pregnancy due to the lowest placental transfer, minimal fetal exposure, and extensive safety data. ### Pharmacokinetic Advantage of Sertraline Sertraline has the highest protein binding (98–99%) and largest molecular weight among SSRIs, resulting in: - **Lowest placental transfer** compared to other SSRIs - Minimal fetal plasma concentrations - Lowest breast milk concentration - Best safety profile in pregnancy and lactation ### Comparison of SSRIs in Pregnancy | SSRI | Placental Transfer | Fetal Risk | Clinical Notes | |------|-------------------|-----------|----------------| | **Sertraline** | **Lowest** | **Minimal** | **First-line; preferred choice** | | Fluoxetine | Moderate | Low | Long half-life; acceptable but not preferred | | Paroxetine | Moderate-High | **Cardiac defects** | **Avoid; associated with congenital heart defects** | | Citalopram | Moderate | Low | Acceptable alternative | | Venlafaxine (SNRI) | Higher | Withdrawal risk | Less data; avoid if possible | **High-Yield:** Paroxetine is contraindicated in pregnancy due to increased risk of cardiac malformations (particularly Ebstein's anomaly) when used in the 1st trimester. Sertraline and fluoxetine are preferred. ### Clinical Pearl The decision to treat depression in pregnancy must balance the risks of untreated maternal depression (preterm delivery, low birth weight, poor maternal-fetal bonding) against medication risks. Sertraline offers the best risk-benefit profile because of its minimal placental transfer and lack of teratogenic effects. ### Mechanism of Safety 1. High protein binding → reduced free drug available for placental transfer 2. Large molecular weight → limited transplacental diffusion 3. Minimal accumulation in fetal tissues 4. No known teratogenic effects across all trimesters **Mnemonic:** **S**ertraline is **S**afest in pregnancy — remember the double S. ### Why Other Agents Are Not Preferred - **Paroxetine:** Teratogenic; associated with cardiac defects and should be avoided - **Fluoxetine:** Safe but longer half-life increases fetal exposure; sertraline preferred - **Venlafaxine:** Limited pregnancy data; SNRI with higher placental transfer; reserved for refractory cases [cite:KD Tripathi 8e Ch 16]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.